bluebird bio Inc (BLUE.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2011||Independent Chairman of the Board|
|44||2010||President, Chief Executive Officer, Director|
|51||2017||Chief Financial and Strategy Officer and Principal Financial Officer, Principal Accounting Officer|
|49||2016||Chief Operating Officer|
|46||2015||Chief Scientific Officer|
- BRIEF-Bluebird Bio appoints Mary Lynne Hedley, Ph.D. to board of directors
- BRIEF-Bluebird Bio Q2 net loss per share $1.73
- BRIEF-Bluebird Bio announces pricing of public offering of common stock
- BRIEF-Bluebird bio reports updated clinical data from starbeam study
- BRIEF-Bluebird Bio, Celgene Corp announce updated clinical results from ongoing first-in-human multicenter study